Form 4: Eton Pharmaceuticals CEO Sells Shares
Insider Transaction (Form 4)
Sean Brynjelsen, President & CEO and a Director of Eton Pharmaceuticals, Inc., sold 100,000 shares of common stock on August 19, 2026.
Summary
- Open-market sale: disposed of 8,978 Common Stock at $62.65 ($562,472) on August 19, 2026; holds 1,052,216 after (Direct).
- Open-market sale: disposed of 47,307 Common Stock at $60.17 ($2,846,462) on August 20, 2026; holds 1,004,909 after (Direct).
- Open-market sale: disposed of 36,373 Common Stock at $61.11 ($2,222,754) on August 20, 2026; holds 968,536 after (Direct).
- Open-market sale: disposed of 7,342 Common Stock at $62.12 ($456,085) on August 20, 2026; holds 961,194 after (Direct).
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $6,087,773 of stock on the open market.
Insider Transactions
Sean Brynjelsen — Director, Officer (President & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Open-market sale | Common Stock | 8,978 | $63 | $562.5K | 1,052,216 |
| 2026-08-20 | Open-market sale | Common Stock | 47,307 | $60 | $2.8M | 1,004,909 |
| 2026-08-20 | Open-market sale | Common Stock | 36,373 | $61 | $2.2M | 968,536 |
| 2026-08-20 | Open-market sale | Common Stock | 7,342 | $62 | $456.1K | 961,194 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Open-market sale (8,978 shares) |
| 2026-08-20 | Open-market sale (47,307 shares) |
| 2026-08-20 | Open-market sale (36,373 shares) |
| 2026-08-20 | Open-market sale (7,342 shares) |
Keywords
insider transaction, Form 4, ETON, Eton Pharmaceuticals, Inc., bearish, Sean Brynjelsen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.